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Nanoparticle conversion to biofilms:
in vitro demonstration using serum-derived
mineralo-organic nanoparticles

Aims: Mineralo-organic nanoparticles (NPs) detected in biological fluids have been
described as precursors of physiological and pathological calcifications in the body.
Our main objective was to examine the early stages of mineral NP formation in
body fluids. Materials & methods: A nanomaterial approach based on atomic force
microscopy, dynamic light scattering, electron microscopy and spectroscopy was used.
Results: The mineral particles, which contain the serum proteins albumin and fetuin-A,
initially precipitate in the form of round amorphous NPs that gradually grow in size,
aggregate and coalesce to form crystalline mineral films similar to the structures
observed in calcified human arteries. Conclusion: Our study reveals the early stages of
particle formation and provides a platform to analyze the role(s) of mineralo-organic
NPs in human tissues.
Keywords: biological fluids • biomineralization • calcium granules • carbonate apatite
• ectopic calcification • mineral biofilms • mineral particles • mineralo-organic interface

Ectopic calcification is found in various
human conditions, including aging, atherosclerosis, cancer, chronic kidney disease and
Type 2 diabetes [1,2] . The presence of vascular calcification correlates with the progression of cardiovascular disease in humans [2] ,
and people with signs of vascular calcification display increased morbidity and mortality risks [2,3] . These observations suggest
that ectopic calcification is detrimental to
human health. Yet the mechanisms regulating ectopic calcification and the formation
of calcified deposits remain incompletely
understood.
Ectopic calcification in vascular tissues is
believed to be initiated by cells that differentiate into osteoblast-like cells and initiate
bone formation in response to inflammation
or excess calcium and phosphate ions [4,5] .
Osteoblast-like cells found in vascular tissues
release lipid-bound vesicles, which resemble
the matrix vesicles that induce mineralization in developing bones [4,5] . Matrix vesicles
may concentrate calcium and phosphate
ions through the action of transporters and
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enzymes that release phosphate ions from
organic compounds. A core of calcium phosphate similar to the mineral found in bones
and teeth forms inside matrix vesicles and
is eventually released in the surrounding
medium to initiate calcification. While progress has been made in our understanding of
vascular calcification, the mechanism of
formation of calcified deposits in biological
fluids remains unclear.
Several studies have reported the detection of amorphous mineral particles in
developing bones and teeth of vertebrates.
Höhling et al. [6] and Robinson [7] have
observed that round mineral nanoparticles
(NPs) represent the first mineral deposited in developing bones and teeth. Similar
mineral NPs have been detected in ectopic calcifications found in soft tissues. For
instance, Jahnen-Dechent and colleagues
have detected fetuin-A-containing calcium
phosphate complexes, which this group
called ‘calciprotein particles,’ in ascitic
fluids of calcifying peritonitis patients [8] .
This group showed that fetuin-A and acidic
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serum proteins participate in the formation and
stabilization of the calcium phosphate complexes,
which may transform with time from small spheres
to large prolate ellipsoid (i.e., ‘secondary calciprotein
particles’) [8] . A recent study by Bertazzo et al. confirmed the presence of mineral NPs in aortic valves
and coronary arteries of both atherosclerotic and
rheumatic fever patients [9] . The possibility that such
mineral NPs may represent precursors of mineral
structures formed in animals and humans remains to
be examined.
Our previous studies have shown that mineraloorganic NPs spontaneously form in human and animal body fluids incubated under cell culture conditions [10–23] . These mineralo-organic NPs have
helped us to resolve a major controversy concerning
the existence of the so-called nanobacteria (NB) –
mineralized entities initially described as the smallest
microorganisms on earth [24] and as the possible cause
of various human diseases, including atherosclerosis,
cancer, kidney stones, polycystic kidney disease and
prostatitis [25–27] . Our work has shown that NB actually represent nonliving mineral NPs that mimic living microorganisms in terms of their shape, growth,
proliferation and subculture [11,18] . Mineralo-organic
NPs similar to NB have been shown to form not only
in human body fluids but also in various organs of
the human body, including in the lungs, blood vessels, kidneys and bones (see [22] for a review of the factors controlling particle formation in the body). The
possibility that these mineralo-organic NPs may play
a role in human diseases is currently under intensive
investigation.
We observed earlier that mineralo-organic NPs
grow in size and number in biological fluids, forming
mineralized structures resembling platelets, spindles

100 nm

and eventually biofilms [11–13] . In the present work,
we used a nanomaterial approach to follow the initial stages of particle formation as well as their transformation from amorphous structures to crystalline
minerals. We also examined the location of organic
molecules within the mineral particles using immunogold labeling and electron microscopy. These
results provide important insights for understanding
the formation of ectopic calcification occurring in the
human body.
Materials & methods
Preparation of mineralo-organic NPs

Human serum (HS) was obtained from healthy volunteers as previously described [11] . The use of human
samples was approved by the Institutional Review
Board of Chang Gung Memorial Hospital (Linkou,
Taiwan). Written informed consent was obtained
from the volunteers. HS-NPs were obtained by adding 3 mM each of CaCl 2 and Na 2HPO4 into Dulbecco’s modified Eagle’s medium (DMEM; Gibco, CA,
USA) containing 0.1–10% HS. The resulting solution was incubated under cell culture conditions in
an incubator (37°C, 5% CO2, humidified air) for the
time indicated. HS-NPs were pelleted by centrifugation at 16,000 × g for 15 min at 4°C prior to two
washing steps using HEPES buffer (20 mM HEPES,
1 mM CaCl 2, 2 mM Na 2HPO4, 150 mM NaCl)
and the same centrifugation conditions. Particles
were also prepared by adding 10 mM of CaCl 2 and
Na 2HPO4 each into DMEM containing 0.1–10%
fetal bovine serum (FBS; Biological industries, Kibbutz Beik Haemek, Isreal), before incubation in cell
culture conditions for the time indicated. All ion
solutions were adjusted to pH 7.4 and sterilized by
filtration through 0.2 μm membranes prior to use.

100 nm

Day 2

100 nm

Day 11

Day 21

Figure 1. Atomic force microscopy observations of mineralo-organic nanoparticles formed in biological fluids.
Mineralo-organic NPs were prepared by adding 10 mM CaCl2 and NaH2PO 4 each into DMEM containing 10%
FBS, followed by incubation under cell culture conditions for (A) 2, (B) 11 and (C) 21 days. Note that the particles
increase in size in a time-dependent manner and some appear to fuse during incubation (in C, arrows denote
particle fusion lines).
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Figure 2. Atomic force microscopy observations and 3D surface profiles of mineralo-organic nanoparticle
specimens. Mineralo-organic NPs prepared as in Figure 1 were observed by atomic force microscopy, either
immediately after mixing precipitating ions at ‘Time 0’ (A) or after incubation in cell culture conditions for 7 days
(B & C). The corresponding 3D surface profiles are shown (D–F). The particles grow in size, fuse and aggregate
with time.

Atomic force microscopy

One drop of particle solution was deposited onto a
glass slide, and the sample was air-dried prior to observation under a multimode scanning probe atomic
force microscope equipped with a NanoScope IV controller (Veeco, NY, USA). Observations were made at
a scan rate of 2 Hz using a resolution of 512 lines per
sample.
Dynamic light scattering measurements

Dynamic light scattering (DLS) measurements were
performed with a Coulter N4 Plus submicron-particle size analyzer (Beckman Coulter, CA, USA). The
samples were transferred to disposable plastic cuvettes
(Kartell, Milan, Italy) and mixed by gentle inversion.
Measurements were performed in triplicate at 25°C at
an incident angle of 90°.
Transmission & scanning electron microscopy

Washed NPs were deposited onto nickel grids (Electron Microscopy Sciences, PA, USA), and excess liquid was removed by using absorbent paper. The grids
were dried overnight under a digital desiccator. The
samples were visualized without fixation or staining
under a JEM 1230 transmission electron microscope
(JEOL, Tokyo, Japan) operated at 100 keV. Control
hydroxyapatite (HAP) consisted of a buffered aqueous
suspension (25% solid; Sigma, MI, USA).

future science group

For scanning electron microscopy (SEM), washed
and dried samples prepared as above were coated
with gold for 90 s. The specimens were observed
with a field-emission SEM S-5000 scanning electron
microscope (Hitachi Science Systems, Tokyo, Japan).
For thin-section transmission electron microscopy
(TEM), washed HS-NPs obtained as above were fixed
for 4 h with a solution of 2.5% glutaraldehyde and
1% paraformaldehyde in ddH2O at 4°C. The particles
were washed three-times with ddH 2O for 10 min each
time. Pellets containing the particles were dehydrated
with successive incubations into 30, 50, 70, 80, 90,
95 and 100% ethanol, for 10 min each time. When
ethanol at 70% was used, the particle pellets were
incubated at 4°C overnight. The other ethanol solutions were only incubated with the pellets for 10 min.
Dehydrated particle pellets were incubated with LR
white-embedding medium (Electron Microscopy Sciences). Various ratios of ethanol and LR medium (3:1,
1:1 and 1:3) were used for 30 min each. Particle pellets
were treated with fresh LR medium (100%) overnight
before polymerization. Pellets were incubated at 60°C
for 2 days to allow polymerization to occur. Blocks
of NP samples were sectioned by using a Leica Ultracut UCT microtome. Sections were stained with 4%
uranyl acetate before observation as described above.
Electron diffraction patterns were acquired under the
same conditions.

www.futuremedicine.com
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Figure 3. Dynamic light scattering measurements of particle size and number during incubation in biological
fluids. (A & B) Mineralo-organic NPs were prepared by adding 0.7 mM CaCl2 and NaH2PO4 each into DMEM
containing FBS at the final concentrations indicated, followed by incubation under cell culture conditions. Particle
size (A) and number (B) were determined using DLS. (C & D) A similar analysis was performed for particles
prepared in HS-DMEM. In (B) and (D), the bars and error bars which are masked by other bars of the graph
correspond to the following relative particle unit values: 2.0 × 105 ± 0.7 × 105 for 10% FBS, 3 days;
2.5 × 105 ± 0.3 × 105 for 10% HS, 3 days; and 0.8 × 105 ± 0.4 × 105 for 0.3% HS, 1 day.
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Production of polyclonal antibodies

Immunogold staining

Five hundred micrograms of either albumin or fetuin-A
(Sigma) were dissolved into DMEM prior to mixing 1:1
with Freund’s complete adjuvant (Sigma). Mixing was
performed with two syringes fixed by a 3-way stopcock
(Nipro Diagnostics, FL, USA). Solutions were injected
intradermally in 3-month-old New Zealand white rabbits. Three weeks after immunization, four boosters
(200 μg of protein mixed with a 1:1 solution of DMEM
and incomplete Freund’s adjuvant) were injected at a
1-month interval. Venous blood was collected from the
ear vein. For apo-A1, 30-kDa SDS-PAGE bands corresponding to 200 μg of protein from whole serum were
used for injections as described above.

Mineralo-organic particles were prepared as for TEM
observation. HS-NPs embedded in resin were cut into
slices of <70-nm thickness. Samples deposited on grids
were blocked with 1% fish gelatin (Sigma) in 0.1 M
HEPES buffer at pH 8.0 for 30 min. Grids were incubated with anti-human serum albumin (α-HSA; 1:30),
anti-human serum fetuin-A (α-HSF; 1:50–1:70), antiapolipoprotein-A1 (α-apo-A1; 1:30) and anti-HSNP (α-HS-NP; 1:60) antibodies. Negative controls
received no primary antibody. Sections were washed
with HEPES buffer for 15 min. Washed samples were
blocked with 1% fish gelatin in HEPES buffer for
10 min. Specimens were treated with the secondary
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5-nm-gold-conjugate goat anti-rabbit IgG (1:20–1:60)
for 1 h. Specimens were washed with HEPES buffer
and ddH2O for 10 min each. TEM observations were
done as described above.
Energy-dispersive X-ray analysis

NP specimens were prepared as for thin-section TEM
observation without staining. Energy-dispersive X-ray
(EDX) spectra were obtained with a high-resolution
JEM 2100 transmission electron microscope (JEOL)
operated at 120 keV. EDX spectra were acquired in
triplicate using an INCA Energy EDS system (Oxford
Instruments, UK).
Powder X-ray diffraction analysis

Washed particle samples were resuspended in ddH2O
and deposited on glass slides for dried overnight under
a laminar flow hood. X-ray diffraction (XRD) analysis
was performed by using a Bruker AXS D5005 X-ray
diffractometer (Bruker, WI, USA). Spectra were compared with the database of the Joint Committee on
Powder Diffraction and Standard for chemical formula
identification.
Results
Formation of mineralo-organic NPs in
biological fluids

To characterize the development of mineral particles in biological fluids, we first prepared mineraloorganic NPs by adding calcium and phosphate ions to
cell culture medium (e.g., DMEM) containing FBS.
We described this precipitation method earlier [11] to

study mineralo-organic NPs similar to the mineral
particles detected in human tissues [8] and to the socalled NB [24–27] . We also studied earlier in detail the
main factors that influence particle formation, including pH, temperature and ion and serum concentrations [11–13] . In the present study, we first observed the
NP samples under atomic force microscopy (AFM) in
order to visualize the mineralization process occurring
at the nanoscale (<100 nm).
The mineral particles were observed at various times
during incubation in cell culture (Figure 1A–C) . Two
days after precipitation, the mineralo-organic NPs
consisted of spherical or ovoidal particles ranging
from 50 to 250 nm in diameter (Figure 1A) . Particle
size gradually increased during incubation ( Figure 1B,
11 days), eventually reaching sizes of approximately
100–350 nm after 3 weeks (Figure 1C) . With time,
the particles fused and formed larger mineral aggregates, as seen by the presence of fusion lines in adjacent
particles ( Figure 1C , arrows).
In order to observe the initial stages of particle formation, we examined particle specimens immediately following precipitation (Figure 2A). Mineral particles that
had just formed were of relatively small size, ranging
between 25 and 100 nm in diameter (Figure 2A). The
smallest particles had a poorly defined border (Figure 2A),
compared with mature particles (Figure 2B & C, 1 week).
The corresponding 3D surface diagrams confirmed that
the particles increased in size and coalesced to form
larger mineral aggregates (Figure 2D vs E & F). After 1
week of incubation, large mineral aggregates that had
fused together were observed (Figure 2B, C, E & F). These

100 nm
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200 nm
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Time 0

Day 1
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Day 7
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Figure 4. Electron microscopy observations of mineralo-organic nanoparticles during incubation in cell culture.
Mineralo-organic NPs derived from FBS-DMEM as described in Figure 1 were prepared for TEM without fixation,
embedding or staining (A–D) and for SEM (E–H) immediately after precipitation (time 0) or following incubation
in cell culture conditions for 1, 7 and 14 days as indicated. Initially, round and distinct following precipitation
(time 0), mineral particles gradually fused and aggregated with time (day 1), eventually forming mineralized
biofilm-like structures (days 7 and 14).
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Figure 5. Morphologies of mineralo-organic nanoparticles during incubation in culture (see facing page).
Mineralo-organic NPs were prepared by adding CaCl2 and Na2HPO4 at 3 mM each into DMEM containing either 1%
FBS (A–F) or 10% HS (G–L) prior to incubation under cell culture conditions for 1 month. After incubation, FBSNPs and HS-NPs were harvested and prepared for thin-section TEM. In samples prepared from either FBS or HS,
mineral NPs formed rings, spindles, aggregates and films. Ring structures showed a hollow cavity while spindles
were solid and fully mineralized. Collapsed aggregates showed a mineralized surface with longer crystalline
projections compared with spindles. Mineralized films contained large (F) or small voids (L), depending on the
samples examined.

observations suggest that mineralo-organic NPs initially
form through an amorphous liquid-like precursor that
gradually increases in size and coalesces with time to
form larger mineral precipitates.
Measurements of particle size & number in
culture

To confirm the increase in size observed under AFM,
we monitored particle size in liquid samples using
DLS. Particles obtained after addition of precipitating
ions in DMEM containing no FBS measured 0.7 μm
in size and increased to 2.4 μm after 24 h of incubation (Figure 3A, 0% FBS). Particle size decreased in a
dose-dependent manner following addition of FBS
(Figure 3A, 0.1–10% FBS), consistent with the presence
of calcification inhibitors such as albumin and fetuinA in serum [11,14,28–31] . Some particles such as the ones
produced with 0.3 and 1% FBS did not grow with time
and even appeared to slightly decrease in size during the
first 24 h of incubation (Figure 3A). Solutions containing 10% FBS produced mineral NPs smaller than 100
nm, and the particles grew slowly during the first 24 h,
remaining stable thereafter (Figure 3A).
We also quantified the proliferation of particles incubated in biological fluids using DLS. The number of
particles in DMEM containing no FBS increased after
precipitation before decreasing to low levels at days 1
and 3 (Figure 3B, 0% FBS). In contrast, particle number
obtained in the presence of FBS gradually increased for
the first 24 h (Figure 3B, 0.1–10% FBS). Addition of FBS
from 0 to 0.3% increased the particle number in a dosedependent manner, while the addition of FBS above
this concentration produced a dose-dependent decrease
in the number of particles (Figure 3B). Similar results
were obtained for HS-NPs, although HS promoted
production of larger particles (Figure 3C & D), consistent
with the high calcification inhibitory effect of FBS compared with HS [11] . These observations are in agreement
with the seeding-inhibition concept described in previous studies [11,13] . According to this model, serum used
at low concentrations can seed mineral particles while
high concentrations inhibit particle formation.
Electron microscopy observations of mineral
particle-to-film conversion

We next observed the morphology of mineralo-organic
particles under TEM without fixation or staining

future science group

(Figure 4A–D) .

Upon formation, mineralo-organic
NPs appeared as small round particles that were either
dispersed or forming aggregates (Figure 4A). During
incubation in biological fluids, the particles gradually increased in size and tended to aggregate further
(Figure 4B) . Strings of particles were also observed
(Figure 4B), consistent with the fusion of particles
observed earlier (Figure 1C) or the possibility that the
particles may serve as nucleators for particle formation by secondary nucleation. With time, the particles
gradually crystallized and coalesced (Figure 4C) to form
crystalline mineral films (Figure 4D). Observations by
SEM confirmed the phenomenon of particle-to-film
conversion as seen by the gradual increase in the size
and number of the particles, until they formed film-like
structures (Figure 4E–H).
We also prepared thin sections of the mineraloorganic NPs for observation by TEM (Figure 5A–L).
In samples of mineralo-organic NPs prepared in FBS
(FBS-NPs), we initially observed half-ring and full-ring
particles (Figure 5A & B). These particles evolved to form
multilamellar rings (Figure 5C), before crystallizing further into spindles (Figure 5D). The particles then gradually coalesced and aggregated (Figure 5E) to form mineral
films (Figure 5F). Similar results were obtained when the
particles were prepared in HS (Figure 5G–L, HS-NPs).
However, the HS-NPs shown here were prepared using
10% HS instead of 1% FBS for FBS-NPs, confirming
our previous observations that FBS produced smaller
particles compared with HS (Figure 3). Using various
electron microscopy techniques, we thus show here
that mineralo-organic NPs undergo a particle-to-film
conversion in biological fluids.
Ultrastructural localization of calcification
inhibitors in mineralo-organic NPs

We observed previously that albumin and fetuinA constantly interact with mineralo-organic NPs
formed in various human body fluids including
serum [11–13] . In order to determine the location of
these proteins within mineralo-organic NPs and their
possible mode of interaction with the mineral phase,
we used immunogold labeling coupled with thinsection TEM. In order to maximize the detection of
mineralo-organic NPs, we prepared rabbit polyclonal
antibodies against mineral particles that had formed
in the presence of albumin and fetuin-A. We verified

www.futuremedicine.com
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Figure 6. Immunogold staining of fetal bovine serum-nanoparticles incubated in body fluids (see facing page).
Mineralo-organic NPs were prepared as in Figure 5, using FBS at 1%. After incubation in cell culture conditions for
1 month, the particles were prepared for thin-section TEM and immunogold staining (A–F). Thin sections were
treated with primary antibodies against fetuin-A (G–L) or albumin (M–R). The secondary antibody alone was used
as negative control (‘unstained’ column). Arrows denote gold NPs bound to mineral particles. Every evolution
stage of mineralization stained positively with the gold-conjugate antibodies directed against either BSF or BSA.
Staining was observed mainly in the electron-dense phase of the particles and films. In the case of ring structures,
both the surface and the inner cavities of the particles were stained with the gold-conjugated antibodies.

earlier the antibodies’ specificity using Western blotting (see [32] for experiments showing the specificity
of the antibodies against human proteins; similar
results were obtained for the corresponding bovine
antibodies against bovine proteins; data not shown).
Using the polyclonal antibodies directed against particles prepared in FBS, we observed that albumin and
fetuin-A were associated with every growth stage of the
mineral particles ( Figure 6G–R, unstained particles are
shown in Figure 6A–F). In half-ring samples, albumin
and fetuin-A appeared to be concentrated on the surface of the particles (Figure 6G & M), while later particle stages showed proteins situated both on the surface
and inside the mineral particles (Figure 6H–L & N–R) .
In late stages, the two serum proteins appeared to be
associated mainly with the dark areas of the mineralo-organic particles (Figure 6I–L & O–R) , indicating
that this zone may contain larger amounts of organic
molecules, compared with electron-lucent areas. Similar results were obtained for particles prepared in HS
( Figure 7, HS-NPs).
Spectroscopy analysis of mineralo-organic NPs

We next studied the chemical composition and crystallographic properties of the mineralo-organic particles formed in body fluids. Using EDX, we observed
major peaks of carbon (C), calcium (Ca), oxygen
(O) and phosphorus (P) in the spectra of the particles (Figure 8G & N) . Minor peaks corresponding to
sodium (Na), zinc (Zn), silicon (Si) and nickel (Ni)
were also observed ( Figure 8G & N, note that the presence of Ni may be due at least in part to the grids
used as a support for this analysis). This EDX profile
was consistent with the presence of calcium phosphate within the mineral particles. The Ca/P atomic
ratios of the representative FBS-NP and HS-NP
samples shown here were 1.47 and 1.15, respectively
(Figure 8G & N) . These values are similar to the theoretical value of 1.67 for pure, stoichiometric HAP [11] ,
the crystal found in bones and teeth of vertebrates [33] .
As described earlier [11] , the minor variability of the
Ca/P ratios measured for mineralo-organic NPs could
be attributed to incomplete crystallization or the presence of impurities and ion substitutions within crystal
lattices.
We used selected area electron diffraction analysis (SAED) and compared the diffraction patterns

future science group

obtained for the various growth stages. Mineraloorganic NPs collected immediately after precipitation showed a pattern of poorly crystallized mineral
( Figure 8A & B, note that concentric rings are barely
visible on the patterns in the insets), while particles
cultured in biological fluids for several days produced
polycrystalline diffraction patterns ( Figure 8C–F, rings
can be clearly observed on these patterns). Similar
results were obtained for particles prepared in HS
(Figure 8H–M) . FBS-NPs and HS-NPs showed diffraction patterns consistent with the presence of a
polycrystalline material of relatively small crystal size,
whereas commercial HAP used as control produced
a pattern representing single crystals of large size
(Figure 9A & B vs C) . Besides, interplanar d-spacing
values of the d (002) reflection calculated for HS-NPs
and FBS-NPs (i.e., 0.340 and 0.346 nm, respectively)
were similar to that of HAP (0.348 nm), thus suggesting that the mineral phase observed for these NPs
may represent HAP.
We also used powder XRD analysis in order to study
the development of mineralo-organic NP samples
during incubation under cell culture conditions
(Figure 10) . We observed that mineralo-organic NPs
were initially amorphous following precipitation
(Figure 10A) , but eventually crystallized during incubation to form calcium phosphate (Figure 10B) and
HAP crystals (Figure 10C & D) . Based on these results,
we conclude that mineralo-organic particles form
from a poorly crystallized calcium phosphate mineral
precursor of small size that gradually converts with
time into crystalline HAP.
Discussion
While ectopic calcification is associated with numerous
human diseases, the factors that induce the formation
of calcified deposits in biological fluids remain poorly
understood. In the present study, we show that mineral
NPs that form in biological fluids gradually develop
into a mineralized biofilm-like structure during incubation in cell culture conditions. This mineral biofilmlike structure is similar to the calcified deposits found
in human arteries and other tissues, and we therefore
believe that the particle-to-film progression described
here may serve as a model for studying the factors that
induce ectopic calcification in vivo. For instance, the
development of mineral biofilms may be used as an
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Figure 7. Immunogold staining of human serum-nanoparticles incubated in body fluids (see facing page).
Mineralo-organic NPs were prepared as in Figure 5, using 10% of HS. Following incubation, the particles were
prepared for thin-section TEM and immunostaining. The samples were treated with anti-fetuin-A antibody (G–L)
or anti-albumin antibody (M–R). The secondary antibody alone was used as a negative control (A–F). Arrows
denote gold NPs. As seen for FBS-NPs in Figure 6, all mineralization stages stained positively with gold-conjugate
antibodies directed against either BSF or BSA. Gold particles were noted mainly within the electron-dense phase
of the particles and films. Both the surface and the inner cavities of the ring structures were stained with the
gold-conjugated antibodies.

assay to screen for possible compounds that can inhibit
the formation of mineral biofilms. These experiments
may prove helpful for developing treatments that can
prevent ectopic calcification and formation of kidney
stones.
Our results support the notion that mineralo-organic
NPs represent precursors of mineralization in the human
body. These NPs have been repeatedly detected in both
physiological and pathological calcification processes in
vivo (reviewed in [22]). Protective mechanisms may be at
work in vivo to limit the formation and crystallization
of these particles in soft tissues in the healthy state. For
instance, calcification inhibitors such as pyrophosphate
or proteins like albumin, fetuin-A, matrix gla protein
and osteopontin, may prevent the precipitation of calcium phosphate in body fluids [34,35] . In addition, macrophages of the reticuloendothelial system are believed
to continually remove these mineral particles from circulation. Accordingly, Jahnen-Dechent and colleagues
showed that mice deficient for fetuin-A show microscopic calcification when fed a mineral-rich diet [36] .
In addition, it was shown that mineralo-organic NPs,
which this group refers as ‘calciprotein particles,’ are
rapidly removed from the circulation by macrophages
of the spleen and liver following intravenous inoculation in mice [37] . The recognition that mineral NPs represent the first stage of calcification may eventually help
us to better recognize and prevent this condition, before
macroscopic-calcified deposits are detected in the body.
Formation of mineral biofilms requires the presence
of an amorphous mineral phase which appears to possess characteristics similar to a liquid phase. The progression from amorphous mineral to a crystalline phase
has attracted considerable attention in recent years, and
the amorphous mineral phase is now recognized to be
involved in the formation of various biomineralization
processes [38–40] . We observed that minerals that precipitate in the presence of organics form round amorphous
mineral particles that possess biomimetic properties
and undergo an amorphous-to-crystalline transition.
We referred to these particles as ‘bions’ to denote the
various ions that can contribute to their composition
as well as the biological nature of the particles [20] . It
should be noted that our use of the term bions is different from that of Reich who coined the term in the late
1930s to describe putative living or preliving vesicles
isolated from decaying grass, soil and animal matter [41]

future science group

(these findings have to our knowledge never been reproduced in any major scientific journal). Further studies
are currently under way to determine the possible role
of amorphous minerals and bions in biomineralization processes including bone formation and ectopic
calcification.
Our results show that mineralo-organic NPs can
form round multi-ring particles. These multi-ring
particles continually form alternating electron-dense
and electron-pervious layers. Amos et al. [42] produced
similar multi-ring mineral particles in vitro by inducing mineral precipitation in the presence of anionic
polypeptide additives. Evan et al. [43] and Ryall [44]
have proposed that the electron-dense layers of multilamellar particles observed in human kidney tissues
may represent organics, while the electron-pervious layers may correspond to minerals. Consistent with these
results, we observed in the present study that albumin
and fetuin-A are mainly located in dark, electron-dense
layers of the particles. Previous studies performed by
us [11–13,16] and others [8,28–31,34–36,45] have shown that
albumin and fetuin-A are consistently associated with
calcium phosphate mineral particles and that these
proteins favor the formation of spherical, amorphous
NPs. These observations and the identification of the
proteins found in the electron-dense layers of the NPs
may facilitate the identification of mineral particles in
human tissues.
Another area of interest is the study of the interactions between the mineralo-organic NPs described here
and cells found in the human body. We have shown
earlier [19] that mineralo-organic NPs are internalized
by human macrophages and that large particles or particle aggregates with a diameter above 1 μm induce the
secretion of pro-inflammatory IL-1β by these cells. We
also reported that mineralo-organic particles activate
the release of neutrophil extracellular traps (NETs)
and that the NETs released by neutrophils may in
turn induce the secretion of TNF-α by bystander
macrophages [Peng HH et al. Mineralo-organic particles
induce innate immunity through neutrophil extracellular
traps containing hmgb1   (2015) , S ubmitted ] . A recent study
by Chen et al. [46] also showed that calcium phosphate
NPs similar to the ones described in the present study
induce the differentiation of rat bone marrow stromal
cells into osteoblast-like cells. Besides, interactions
between mineralo-organic NPs and the extracellular
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Figure 8. Selected area electron diffraction analysis of mineralo-organic nanoparticles prepared in serum
(see also facing page). Mineralo-organic NPs were prepared as in Figure 5, using either 1% FBS (A–G) or 10%
HS (H–N). Following incubation, the particles were prepared for thin-section TEM and SAED analysis. Electron
diffraction patterns (insets at the top right of each TEM image) revealed that the forming particles were initially
poorly crystalline and gradually converted into polycrystalline mineral particles. EDX analysis suggested that the
particles consist of calcium phosphate containing minor additional elements (G & N).

matrix also represent a topic worthy of further studies as seen by the observation that extracellular matrix
proteins control the formation of calcium phosphate
particles during bone and tooth formation [47] , and
these proteins may also play a role in ectopic calcification. Further studies are needed to examine these
phenomena in more detail.
A previous study by Schwartz et al. examined the
effects of various biochemical treatments on the formation of mineral biofilms derived from calcified human
samples [48] . This study showed that RNAse failed to
influence biofilm formation while the antibiotic drugs
gentamycin and tetracycline completely inhibited this
process [48] . In addition, the same study showed that
mineral biofilms stained with concanavalin A (a carbohydrate-binding protein or lectin) and BacLight green
(a commercial kit used to differentiate living bacteria
from dead ones). While such results give the impression that living and enzymatic processes are necessary
for the formation of mineral NPs and biofilms, we have
shown here that mineralized biofilms can be derived
from the precipitation of inorganic mineral NPs in
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the presence of organic molecules derived from body
fluids. This conclusion is consistent with our previous
observations that NB and calcifying NPs represent
non-living mineral NPs that mimic living organisms
in various ways [14,18] . Accordingly, we have shown that
the whole NB phenomenology can be re-interpreted
in terms of the interactions between minerals and
organic moieties found in body fluids [11,14,18] . This
simple explanation can fully account for the observations of NB and calcifying NPs in the human body and
biological fluids.
Conclusion
We have shown that mineralo-organic NPs similar to the
particles described in human tissues differentiate to form
mineral biofilms during incubation in biological fluids.
The serum proteins albumin and fetuin-A are associated
with all growth stages of mineralo-organic NPs derived
from body fluids, especially with the electron-dense phase
of the particles. These findings support the concept that
the mineralo-organic NPs detected in human tissues may
represent precursors of calcification in the human body.
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FBS-NPs

2 1/nm
HS-NPs

Figure 9. Selected area electron diffraction analysis
of mineralo-organic nanoparticles. Mineralo-organic
NPs were prepared as in Figure 5, using either 1% FBS
(A) or 10% HS (B). The particles were prepared for
thin-section TEM and SAED analysis as described in
the ‘Materials & methods’ section. Commercial HAP
was analyzed in the same manner for comparison (C).
Notice the presence of faint concentric rings showing
a polycrystalline nanomaterial containing multiple
crystals of relatively small sizes for FBS-NPs and HS-NPs,
whereas commercial HAP produced an array of dots
showing the presence of relatively large single crystals
(with sizes averaging 100 ± 50 nm).

priate markers for the detection of calcium phosphate
NPs in human tissues. We expect that future studies will
be performed to describe in more detail the formation of
mineralo-organic NPs in the human body as well as their
role in human health and disease.
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Figure 10. Powder X-ray diffraction analysis of mineralo-organic nanoparticle specimens. Mineralo-organic NPs
were prepared as in Figure 5, using FBS at 1%. Particles were analyzed immediately after precipitation (A) or
following incubation for 1 day (B), 1 week (C) and 1 month (D). Following incubation, the particles were prepared
for XRD analysis as described in the ‘Materials & methods’ section. This XRD analysis showed that the amorphous
particles obtained following precipitation in (A) gradually crystallized with time as seen with the diffraction peak
observed in (B) and the multitude of peaks corresponding to HAP in (C) and (D).

Executive summary
Formation of mineralo-organic nanoparticles in biological fluids
• Mineral particles that precipitate in biological fluids form round amorphous nanoparticles (NPs) that gradually
grow in size, aggregate and coalesce to form crystalline mineral biofilm-like structures.
• The mineral biofilm-like structures resemble mineral deposits observed in calcified human arteries and ectopic
calcifications.

Localization of serum proteins in mineralo-organic NPs
• The serum proteins albumin and fetuin-A are associated with all growth stages of the mineral particles and
are found within electron-dense areas.

Possible role of mineralo-organic NPs in the human body
• Mineralo-organic NPs detected in human tissues may represent precursors that evolve to form crystalline
mineral deposits similar to the ones found in mineralized tissues and ectopic calcification.

Future perspective
• The experimental methodology employed here may be used to study the process of ectopic calcification
occurring in human body fluids and soft tissues.
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